protoporphyrin ix has been researched along with Kahler Disease in 1 studies
protoporphyrin IX: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7685
protoporphyrin : A cyclic tetrapyrrole that consists of porphyrin bearing four methyl substituents at positions 3, 8, 13 and 17, two vinyl substituents at positions 7 and 12 and two 2-carboxyethyl substituents at positions 2 and 18. The parent of the class of protoporphyrins.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5-Aminolevulinic acid (ALA) is a natural compound in the heme biosynthesis pathway." | 5.51 | Flow Cytometry-Based Photodynamic Diagnosis with 5-Aminolevulinic Acid for the Detection of Minimal Residual Disease in Multiple Myeloma. ( Fujimaki, S; Fujiwara, M; Fujiwara, T; Fukuhara, N; Harigae, H; Ito, T; Iwaki, K; Onishi, Y; Ono, K; Saito, K; Sasaki, K; Suzuki, C; Tamura, H; Tanaka, T; Yokoyama, H, 2019) |
| "5-Aminolevulinic acid (ALA) is a natural compound in the heme biosynthesis pathway." | 1.51 | Flow Cytometry-Based Photodynamic Diagnosis with 5-Aminolevulinic Acid for the Detection of Minimal Residual Disease in Multiple Myeloma. ( Fujimaki, S; Fujiwara, M; Fujiwara, T; Fukuhara, N; Harigae, H; Ito, T; Iwaki, K; Onishi, Y; Ono, K; Saito, K; Sasaki, K; Suzuki, C; Tamura, H; Tanaka, T; Yokoyama, H, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwaki, K | 1 |
| Fujiwara, T | 1 |
| Ito, T | 1 |
| Suzuki, C | 1 |
| Sasaki, K | 1 |
| Ono, K | 1 |
| Saito, K | 1 |
| Fukuhara, N | 1 |
| Onishi, Y | 1 |
| Yokoyama, H | 1 |
| Fujimaki, S | 1 |
| Tanaka, T | 1 |
| Tamura, H | 1 |
| Fujiwara, M | 1 |
| Harigae, H | 1 |
1 other study available for protoporphyrin ix and Kahler Disease
| Article | Year |
|---|---|
Flow Cytometry-Based Photodynamic Diagnosis with 5-Aminolevulinic Acid for the Detection of Minimal Residual Disease in Multiple Myeloma.
Topics: Aminolevulinic Acid; Cell Line, Tumor; Flow Cytometry; gamma-Aminobutyric Acid; Humans; Leukocytes; | 2019 |